Evidence map›Paper›PMID 38698772›Full record

ArticleFrontiers in molecular biosciences2024

Risk factors and metabolomics of mild cognitive impairment in type 2 diabetes mellitus.

Tao Luo, Xiao Jiang, Ning Xu, Xinyu Zhao, Xingjie Xie, Xiuwen Xia, XiaoLong Bian, Haixia Liu

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in molecular biosciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Illuminating diabetesWorld journal of diabetes · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Tao Luo *Endocrinology and Metabolism Department, The Second Affiliated Hospital of Dalian Medical University, Dalian, China.
Xiao Jiang *Endocrinology and Metabolism Department, The Second Affiliated Hospital of Dalian Medical University, Dalian, China.
Ning Xu *Endocrinology Department, The Second Hospital of Chao Yang, Chaoyang, China.
Xinyu ZhaoEndocrinology and Metabolism Department, The Second Affiliated Hospital of Dalian Medical University, Dalian, China.
Xingjie XieEndocrinology and Metabolism Department, The Second Affiliated Hospital of Dalian Medical University, Dalian, China.
Xiuwen XiaEndocrinology and Metabolism Department, The Second Affiliated Hospital of Dalian Medical University, Dalian, China.
XiaoLong BianThe Second Clinical College, Dalian Medical University, Dalian, China.
Haixia LiuEndocrinology and Metabolism Department, The Second Affiliated Hospital of Dalian Medical University, Dalian, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

LPCmetabolomicsmild cognitive impairmentrisk factorstype 2 diabetes mellitus

Identifiers

PMID38698772
PMCPMC11063278

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.